Table 1 Baseline clinical characteristics of patients
Characteristic | AIOD Patients with TASC-II C and D lesions (No, %; Mean ± SD) |
|---|---|
Gender | |
Male | 22 (84.6%) |
Female | 4 (15.4%) |
Age (y) | 62.2 ± 7 |
Body mass index, kg/m2 | 24.2 ± 2.6 |
Preoperative ABI | 0.33 ± 0.14 |
Rutherford category | |
1–3 | 6 (23.1%) |
4–6 | 20 (76.9%) |
TASC lesion type | 18.9 ± 17.2 |
C | 6 (23.1%) |
D | 20 (76.9%) |
Comorbidities | |
Hypertension | 9 (34.6%) |
Diabetes mellitus | 6 (23.1%) |
Dyslipidemia | 5 (19.2%) |
Coronary artery disease | 3 (11.5%) |
Smoking | 19 (73.1%) |
Cerebrovascular disease | 3 (11.5%) |
Hemoglobin (g/dL) | 133.8 ± 11.7 |
Albumin (g/dL) | 38.3 ± 3.1 |
Creatinine (mg/dL) | 83.1 ± 12.4 |
BUN (mmol/L) | 4.4 ± 0.7 |
GFR (mL/min/1.73m2) | 88.2 ± 12.2 |
Puncture approach | |
Bilateral femoral artery | 5 (19.2%) |
Brachial and femoral arteries | 21 (80.8%) |
Operation time, min | 90.5 ± 33.7 |